comparemela.com
Home
Live Updates
Gautam Borthukar - Breaking News
Pages:
Latest Breaking News On - Gautam borthukar - Page 1 : comparemela.com
Treadwell Therapeutics Announces A Presentation at the 2022 ASH Annual Meeting Featuring a Clinical Trial Update on CFI-400945, an oral PLK4 inhibitor
/PRNewswire/ Treadwell Therapeutics, a clinical-stage biotechnology company developing novel, small molecule therapeutics for highly aggressive cancers,.
United states
Gautam borthukar
Division of cancer medicine
American society of hematology
Department of leukemia
Md anderson cancer center
Treadwell therapeutics
Polo like kinase
American society
Annual meeting
Principal investigator
Cancer medicine
Michael tusche
Dose optimization clinical study
Single agent
Acute myeloid leukemia
vimarsana © 2020. All Rights Reserved.